FI
ATNM icon

Fosun International’s Actinium Pharmaceuticals ATNM Stock Holding History

Fosun International’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,628
Closed -$42K – 240
2019
Q2 		$42K Hold
5,628
– – ﹤0.01% 298
2019
Q1 		$78K Sell
5,628
-1,876
-25% -$30K 0.01% 302
2018
Q4 		$87K Hold
7,504
– – 0.01% 295
2018
Q3 		$170K Buy
+7,504
New +$153K 0.01% 237

Other funds holding ATNM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Fosun International's ATNM Position: Q3 2019 in Review

Fosun International sold out of Actinium Pharmaceuticals (ATNM) in Q3 2019, closing a stake of 19,892 shares — an estimated $147K sold.

Fosun International first reported a position in ATNM in Q1 2019 and held it in 2 quarters. The position peaked at $147K in Q2 2019. 40 funds tracked by Wall St. Rank hold ATNM as of Q3 2019.

  • Fosun International reported no remaining Actinium Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 19,892 Actinium Pharmaceuticals shares in Q3 2019, an estimated $147K.
  • Fosun International first reported a position in Actinium Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Fosun International's Actinium Pharmaceuticals position peaked at $147K in Q2 2019.
  • 40 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.